The Phase Ia single-center clinical trial evaluated the safety, tolerability, pharmacokinetic profile, and pharmacological activity of CR845 in a double-blind, randomized, placebo-controlled, single escalating intravenous dose study in
The patent covers, amongst others, compositions where the active ingredient is selected from mesalazine, budesonide, metformin, octylonium bromide, gabapentin, carbidopa, nimesulide, propionylcarnitine, isosorbide mono- and dinitrate, naproxen, ibuprofen,
Under the agreement Aquapharm will use its proprietary assays to screen its library of marine microbes for the discovery and generation of novel cosmetic ingredients for skin and
Dr Mazzo brings to Regado almost 25 years of experience in the pharmaceutical industry, most recently as president and CEO of Aeterna Zentaris. Dr Mazzo earned a bachelor
As part of the agreement, Abingdon will provide clinical and regulatory services for Stason’s pipeline of potential drug candidates and devices in the areas of cancer and inflammation.
The product will be manufactured by Alkermes and commercialized by Janssen-Cilag, an affiliate company of Cilag International. Alkermes and Cilag have previously announced an exclusive agreement to commercialize
Under the terms of the settlement, Inhibitex agreed to pay Nabi a total of $2.2 million, $1.7 million in connection with the execution of settlement and $0.5 million
Through GeneWize, its wholly owned subsidiary, GeneLink has successfully launched the first direct selling industry company to focus exclusively on marketing nutritional supplements and skin care products specifically
According to the company, the PhenoSense integrase assay directly measures the susceptibility of HIV to a new and potent class of integrase inhibitor drugs that blocks viral replication
Under the agreement, Patent Profit International (PPI) will market Health Discovery’s (HDC) patent portfolio, which includes exclusive rights to support vector machine techniques and applications that reach far
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.